IBDEI0KB ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8962,1,3,0)
 ;;=3^Kidney Transplant Failure
 ;;^UTILITY(U,$J,358.3,8962,1,4,0)
 ;;=4^T86.12
 ;;^UTILITY(U,$J,358.3,8962,2)
 ;;=^5055710
 ;;^UTILITY(U,$J,358.3,8963,0)
 ;;=T86.13^^69^613^5
 ;;^UTILITY(U,$J,358.3,8963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8963,1,3,0)
 ;;=3^Kidney Transplant Infection
 ;;^UTILITY(U,$J,358.3,8963,1,4,0)
 ;;=4^T86.13
 ;;^UTILITY(U,$J,358.3,8963,2)
 ;;=^5055711
 ;;^UTILITY(U,$J,358.3,8964,0)
 ;;=Z94.0^^69^613^7
 ;;^UTILITY(U,$J,358.3,8964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8964,1,3,0)
 ;;=3^Kidney Transplant Status
 ;;^UTILITY(U,$J,358.3,8964,1,4,0)
 ;;=4^Z94.0
 ;;^UTILITY(U,$J,358.3,8964,2)
 ;;=^5063654
 ;;^UTILITY(U,$J,358.3,8965,0)
 ;;=Z48.22^^69^613^1
 ;;^UTILITY(U,$J,358.3,8965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8965,1,3,0)
 ;;=3^Aftercare Following Kidney Transplant
 ;;^UTILITY(U,$J,358.3,8965,1,4,0)
 ;;=4^Z48.22
 ;;^UTILITY(U,$J,358.3,8965,2)
 ;;=^5063039
 ;;^UTILITY(U,$J,358.3,8966,0)
 ;;=Z52.4^^69^613^2
 ;;^UTILITY(U,$J,358.3,8966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8966,1,3,0)
 ;;=3^Kidney Donor
 ;;^UTILITY(U,$J,358.3,8966,1,4,0)
 ;;=4^Z52.4
 ;;^UTILITY(U,$J,358.3,8966,2)
 ;;=^5063082
 ;;^UTILITY(U,$J,358.3,8967,0)
 ;;=D47.Z1^^69^613^8
 ;;^UTILITY(U,$J,358.3,8967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8967,1,3,0)
 ;;=3^Post-Transplant Lymphoproliferative Disorder (PTLD)
 ;;^UTILITY(U,$J,358.3,8967,1,4,0)
 ;;=4^D47.Z1
 ;;^UTILITY(U,$J,358.3,8967,2)
 ;;=^5002261
 ;;^UTILITY(U,$J,358.3,8968,0)
 ;;=N18.1^^69^614^1
 ;;^UTILITY(U,$J,358.3,8968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8968,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,8968,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,8968,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,8969,0)
 ;;=N18.2^^69^614^2
 ;;^UTILITY(U,$J,358.3,8969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8969,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,8969,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,8969,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,8970,0)
 ;;=N18.3^^69^614^3
 ;;^UTILITY(U,$J,358.3,8970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8970,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,8970,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,8970,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,8971,0)
 ;;=N18.4^^69^614^4
 ;;^UTILITY(U,$J,358.3,8971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8971,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,8971,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,8971,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,8972,0)
 ;;=N18.5^^69^614^5
 ;;^UTILITY(U,$J,358.3,8972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8972,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,8972,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,8972,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,8973,0)
 ;;=N18.9^^69^614^6
 ;;^UTILITY(U,$J,358.3,8973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8973,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,8973,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,8973,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,8974,0)
 ;;=N18.6^^69^614^7
 ;;^UTILITY(U,$J,358.3,8974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8974,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,8974,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,8974,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,8975,0)
 ;;=N19.^^69^614^8
